Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: The Casale Monferrato Study

Diabetologia

Volumn 48, Issue 3, 2005, Pages 427-434

  Bruno, G ^a   Merletti, F ^b   Biggeri, A ^c   Bargero, G ^d   Ferrero, S ^a   Pagano, G ^a   Cavallo Perin, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

Diabetic nephropathy; Fibrinogen; Mortality; Survey

Indexed keywords

ALBUMIN; FIBRINOGEN; HEMOGLOBIN A1C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MICROALBUMINURIA; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; ITALY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK; TIME FACTORS;

EID: 16844363186     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1667-1     Document Type: Article

References (35)

1. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P (1999) The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 19:1776-1783
2. Yano K, Grove JS, Chen R, Rodriguez BL, Curb JD, Tracy RP (2001) Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men. Arterioscler Thromb Vasc Biol 21:1065-1070
3. Yarnell JWG, Patterson CC, Sweetnam PM, Lowe GDO (2004) Haemostatic/inflammatory markers predict 10-yr risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J 25:1049-1056
4. Engström G, Hedblad B, Stavenow L et al (2004) Fatality of future coronary events is related to inflammation-sensitive plasma proteins. A population-based prospective cohort study. Circulation 110:27-31
5. Engström G, Stavenow L, Hedblad B et al (2003) Inflammation- sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke. A population-based study. Diabetes 52:442-447
6. Stehouwer CD, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157-1165
7. Bosnyak Z, Forrest KY, Maser RE, Becker D, Orchard TJ (2003). Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med 20:147-151
8. Greaves M, Malia RG, Goodfellow K et al (1997) Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Diabetologia 40:698-705
9. Klein RL, Hunter SJ, Jenkins AJ et al (2003) Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care 26:1439-1448
10. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G (1996) The associations of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes. Ann Intern Med 125:653-657
11. Bruno G, Merletti F, Biggeri A et al (2003) Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 26:2150-2155
12. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418
13. Forsblom CM, Sane T, Groop P-H et al (1998) Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence for a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41:1253-1262
14. Gerstein HC, Mann JFE, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426
15. Valmadrid CT, Klein R, Moss SE, Klein BE (2000) The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093-1100
16. Yuyun MF, Dinnen SF, Edwards OM, Wood E, Warehan NJ (2003) Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 20:277-282
17. Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS (1995) Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013-1016
18. Agewall S, Wikstrand J, Ljungman S, Fagerberg B, Risk Factor Intervention Study Group (1997) Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Am J Cardiol 80:164-169
19. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H (1995) Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303-1309
20. MacLeod JM, Lutale J, Marshall SM (1995) Albumin excretion and vascular deaths in NIDDM. Diabetologia 38:610-616
21. Östgren CJ, Lindblad U, Melander A, Råstam L (2002) Survival in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project. Diabetes Care 25:1297-1302
22. Hillege HL, Fidler V, Diercks GFH et al (2002) Urinary albumin excretion predicts cardiovascular and non cardiovascular mortality in general population. Circulation 106:1777-1782
23. Fuller JH, Stevens LK, Wang S-L, WHO Multinational Study Group (2001) Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S54-S64
24. Mattock MB, Barnes DJ, Viberti GC et al (1998) Microalbuminuria and coronary heart disease in NIDDM. An incidence study. Diabetes 47:1786-1792
25. Bruno G, Cavallo-Perin P, Bargero G et al (1996) Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of non-insulin-dependent diabetic subjects. Diabetes Care 19:43-47
26. Bruno G, Cavallo-Perin P, Bargero G et al (1999) Cardiovascular risk profile of type 2 diabetic patients cared for by general practitioners or by a diabetes clinic: a population-based study. J Clin Epidemiol 52:413-417
27. Bruno G, LaPorte R, Merletti F, Biggeri A, McCarty D, Pagano G (1994) National diabetes programmes: application of capture-recapture to "count" diabetes? Diabetes Care 17:548-556
28. Bruno G, Biggeri A, Merletti F et al (2003) Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes. A 10-year prospective study. Diabetes Care 26:2353-2358
29. Schoenfeld D (1982) Partial residuals for the proportional hazards regression model. Biometrika 69:239-241
30. Ritz E (2003) Albuminuria and vascular damage. The vicious twins. N Engl J Med 348:2349-2352
31. Hanley AJG, Festa A, D'Agostino RB et al (2004) Metabolic and inflammation variable clusters and prediction of type 2 diabetes. Factor analysis using directly measured insulin sensitivity. Diabetes 53:1773-1781
32. Bruno G, Cavallo-Perin P, Bargero G et al (2001) Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study. Diabetes Metab Res Rev 17:124-130
33. Ceriello A (1997) Fibrinogen and diabetes mellitus: is it time for intervention trials? Diabetologia 40:731-734
34. Kirk A, Mutrie N, MacIntyre P, Fisher M (2004) Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with type 2 diabetes. Diabetologia 47:821-832
35. Zoppini G, Verlato G, Bonora E, Muggeo M (1999) Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes Study. Diabetes Metab Res Rev 15:170-174